Stevens–Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management

R Frantz, S Huang, A Are, K Motaparthi - Medicina, 2021 - mdpi.com
Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are rare diseases
that are characterized by widespread epidermal necrosis and sloughing of skin. They are …

Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta-analysis

TY Tsai, IH Huang, YC Chao, H Li, TS Hsieh… - Journal of the American …, 2021 - Elsevier
Background Various systemic immunomodulating therapies have been used to treat toxic
epidermal necrolysis (TEN), but their efficacy remains unclear. Objective To perform a …

[HTML][HTML] Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States

RG Micheletti, Z Chiesa-Fuxench, MH Noe… - Journal of Investigative …, 2018 - Elsevier
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe
mucocutaneous reaction with few large cohorts reported. This multicenter retrospective …

Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis

M Kinoshita, Y Ogawa, N Hama, I Ujiie… - Science translational …, 2021 - science.org
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
mucocutaneous adverse drug reactions characterized by massive epidermal detachment …

Mechanisms of severe cutaneous adverse reactions: recent advances

T Bellón - Drug safety, 2019 - Springer
Cutaneous adverse drug reactions are unpredictable and include various different skin
conditions of varying degrees of severity. The most concerning are usually referred to as …

British Association of Dermatologists' guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis in children and young people, 2018

T McPherson, LS Exton, S Biswas… - British Journal of …, 2019 - academic.oup.com
British Association of Dermatologists' guidelines for the management of Stevens–Johnson
syndrome/toxic epidermal necrolysis in children and young people, 2018 | British Journal of …

An updated review of genetic associations with severe adverse drug reactions: Translation and implementation of pharmacogenomic testing in clinical practice

CW Wang, IAC Preclaro, WH Lin… - Frontiers in …, 2022 - frontiersin.org
Adverse drug reactions (ADR) remain the major problems in healthcare. Most severe ADR
are unpredictable, dose-independent and termed as type B idiosyncratic reactions. Recent …

[HTML][HTML] Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis

L Lucia, C Silvia, B Paolo, B Roberto… - Acta Bio Medica …, 2019 - ncbi.nlm.nih.gov
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which can be
considered a late-onset allergic reaction, can cause serious long-term sequelae. SJS/TEN …

[HTML][HTML] Toxic epidermal necrolysis post COVID-19 vaccination-first reported case

M Bakir, H Almeshal, R Alturki, S Obaid, A Almazroo - Cureus, 2021 - ncbi.nlm.nih.gov
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a spectrum of acute,
delayed-type hypersensitivity reactions that affect the skin and the mucous membranes …

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

RY Pan, MT Chu, CW Wang, YS Lee… - Nature …, 2019 - nature.com
Drug hypersensitivity such as severe cutaneous adverse reactions (SCAR), including
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), could be life …